Cat Kidney Disease Advanced Management

Chronic kidney disease is the leading cause of death in older cats and requires sophisticated management to maximize quality of life.

Key Facts

CKD affects approximately 30-40% of cats over 15 years of age
The IRIS staging system classifies CKD severity and guides treatment decisions
Phosphorus restriction through diet is the single most important intervention for slowing CKD progression
Subcutaneous fluid therapy provided at home significantly improves quality of life in later-stage CKD cats
Anti-nausea medications including maropitant significantly improve appetite and comfort in CKD cats
Hypertension affects 20-65% of CKD cats and requires treatment to prevent target organ damage
New treatments including benazepril and telmisartan reduce glomerular filtration pressure and slow progression

Welfare Considerations

Feline CKD welfare management is a long-term commitment that can maintain quality of life for years beyond initial diagnosis with appropriate treatment. The welfare priorities are nausea management (ensuring cats eat comfortably), blood pressure control (preventing blindness and neurological damage), and phosphorus restriction (slowing disease progression). Home subcutaneous fluid administration, while initially intimidating for owners, is transformative for cat comfort — owners consistently report dramatic behavioral improvement after beginning fluid therapy. The welfare trajectory of CKD is significantly better when diagnosed early through screening and managed proactively rather than reactively.

What You Can Do

Screen cats over 7 annually for kidney disease through bloodwork and urine testing
Discuss phosphorus-restricted prescription diets with your veterinarian at CKD diagnosis
Learn home subcutaneous fluid administration for cats with later-stage CKD after veterinary instruction
Monitor blood pressure and treat hypertension promptly to prevent vision loss
Ask your veterinarian about anti-nausea medications to improve comfort and appetite